| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 701.985 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 828.211 | 95 |
| GSM780709 | Untreated after 4 days (C3_1) | 760.979 | 94 |
| GSM780719 | Untreated after 4 days (C1_2) | 663.247 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 866.263 | 95 |
| GSM780721 | Untreated after 4 days (C3_2) | 777.568 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 882.487 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 668.389 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 699.311 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 838.748 | 95 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 755.201 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 871.23 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 544.821 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 757.684 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 652.275 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 569.087 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 717.982 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 648.058 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 702.983 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 670.581 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 686.274 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 717.25 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 697.211 | 94 |